Detailed answers about NIGHTINGALES MEDICAL BILLING HOLDINGS LIMITED, including incorporation, status, business activity, and accounts information.
When was NIGHTINGALES MEDICAL BILLING HOLDINGS LIMITED founded?
NIGHTINGALES MEDICAL BILLING HOLDINGS LIMITED was officially incorporated on 20 July 2026 and is registered under company number 17348103. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is NIGHTINGALES MEDICAL BILLING HOLDINGS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of NIGHTINGALES MEDICAL BILLING HOLDINGS LIMITED?
NIGHTINGALES MEDICAL BILLING HOLDINGS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does NIGHTINGALES MEDICAL BILLING HOLDINGS LIMITED do?
NIGHTINGALES MEDICAL BILLING HOLDINGS LIMITED operates in the following sector: 64209 - Activities of other holding companies n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is NIGHTINGALES MEDICAL BILLING HOLDINGS LIMITED's registered address?
The registered office address of NIGHTINGALES MEDICAL BILLING HOLDINGS LIMITED is Ground Floor, Kings House, 101-135 Kings Road, Brentwood, Essex, United Kingdom, CM14 4DR. This is the official address filed with Companies House for legal and statutory correspondence.
Is NIGHTINGALES MEDICAL BILLING HOLDINGS LIMITED financially stable?
Financial accounts for NIGHTINGALES MEDICAL BILLING HOLDINGS LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.